Astellas US Technologies
$6.9M 0 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Johnson & Johnson Vision Care, Inc.
Johnson & Johnson Vision Care, Inc. reported $6,827,033.83 across General Payments, Research, and Ownership to 29,358 physicians and teaching hospitals across 29,585 transactions.
- $6.8M Top quartile payer
- All-tracks total
- 29,585 Top 10% volume
- Transactions
- 29,358 Top 10% reach
- Recipients
- −$694.0K
- General Payments vs PY2023
Johnson & Johnson Vision Care, Inc. reported $6,827,033.83 across all CMS Open Payments tracks (General + Research + Ownership) to 29,358 physicians and teaching hospitals in Program Year 2024 - ranking #225 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $3,194,644.32, averaging $232.54 per recipient.
How Johnson & Johnson Vision Care, Inc.'s $6.8M all-tracks total breaks down
Johnson & Johnson Vision Care, Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
A
93/100
Total payments
C
73/100
Transaction volume
A
100/100
Physician reach
A
100/100
Payment type diversity
A
100/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer johnson-johnson-vision-care-inc Johnson & Johnson Vision Care, Inc.
$6.8M · #225/1,925 · 0.0% industry · PY2024
- TOT $6.8M
- RANK #225
- SHARE 0.0%
- TXN 29,585
- RCP 29,358
- CAT 8
- GEN $3.2M
- ΔGEN −$694.0K
- TOP1 16.8%
- PY 2024
Volume peers
Nearest volume peer: Astellas US Technologies ($6.9M)
Johnson & Johnson Vision Care, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Johnson & Johnson Vision Care, Inc.'s CMS-reported General Payments decreased by $694.0K (−17.8%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: JOHNSON & JOHNSON VISION CARE, INC.PY2023: JOHNSON & JOHNSON VISION CARE, INC.PY2024: Johnson & Johnson Vision Care, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $3,888,649.72
- PY2024
- $3,194,644.32
What the Data Shows for Johnson & Johnson Vision Care, Inc.
CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For Johnson & Johnson Vision Care, Inc., that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.
456 transactions worth $1.4M make "Compensation for Services Other Than Consulting" the top general-payment category in the 8-category breakdown below, 43.2% of General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Across 8 types of general payments, Johnson & Johnson Vision Care, Inc.'s largest category was "Compensation for Services Other Than Consulting" at $1.4M - 43.2% of General Payments.
Johnson & Johnson Vision Care, Inc. reports 8 general-payment categories - the top three are Compensation for Services Other Than Consulting (43.2%), Food and Beverage (31.0%), and Travel and Lodging (12.3%). The remaining 5 categories make up 13.6% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
Category breadth matters here: Johnson & Johnson Vision Care, Inc. files across 8 named CMS general-payment types in Program Year 2024, versus manufacturers that report a single dominant category. The chart and table below enumerate every type with an amount above zero for this company.
How Johnson & Johnson Vision Care, Inc. divides its payments
Ranked by total dollars reported per category
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Compensation for Services Other Than Consulting | $1.4M | 456 | 43.2% |
| Food and Beverage | $988.8K | 26,698 | 31.0% |
| Travel and Lodging | $392.0K | 1,544 | 12.3% |
| Consulting Fee | $365.8K | 497 | 11.5% |
| Royalty or License | $67.5K | 3 | 2.1% |
| Education | $1.1K | 134 | 0.0% |
| Space Rental or Facility Fees | $400.00 | 1 | 0.0% |
| Gift | $44.00 | 25 | 0.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $861,498.18 (27.0%) of $3,194,644.32 in this company's General Payments records across 11,564 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Johnson & Johnson Vision Care, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Matthew David Geller
$538,125.00 across 8 reported transactions
- 2
Sophia Visanji
$85,114.74 across 139 reported transactions
- 3
Jennifer E Lyerly
$85,024.00 across 2 reported transactions
- 4
Melody D Tavakoli
$80,674.07 across 177 reported transactions
- 5
Denise M Whittam
$72,560.37 across 112 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Johnson & Johnson Vision Care, Inc. ranks #225 of 1,925 by total payments (top 12% by spend) but spreads that money notably more broadly than its spend rank alone would suggest -- #1,412 of 1,838 by HHI (bottom 23% least concentrated), a wider distribution than most similarly sized payers.
View all 12 companies in this HHI neighborhood as a list
- Vilex LLC : $1.1M total payments, HHI 363
- 4WEB, Inc. : $141.8K total payments, HHI 362
- Sawtooth Surgical Solutions Inc : $23.1K total payments, HHI 359
- Invictus Surgical Incorporated : $23.2K total payments, HHI 358
- Spineology Inc. : $535.2K total payments, HHI 356
- Mauna Kea Technologies, Inc. : $31.0K total payments, HHI 356
- Johnson & Johnson Vision Care, Inc. (this company) : $3.2M total payments, HHI 355
- MicroVention, Inc. : $3.4M total payments, HHI 355
- United Therapeutics Corporation : $4.3M total payments, HHI 355
- Dornier MedTech America, Inc : $4.3K total payments, HHI 354
- Moximed, Inc : $1.8K total payments, HHI 353
- Edwards Lifesciences Corporation : $27.8M total payments, HHI 353
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Johnson & Johnson Vision Care, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Johnson & Johnson Vision Care, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Johnson & Johnson Vision Care, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Aptis Medical, LLC
$6.8M 95 recipients
Compare payment profiles
Astellas Pharma Inc
$6.9M 81 recipients
Compare payment profiles
Dompe Farmaceutici S.p.A.
$6.9M 7 recipients
Compare payment profiles
GLW, Inc
$6.7M 11 recipients
Compare payment profiles
Woven Orthopedic Technologies, LLC
$7.0M 11 recipients
Compare payment profiles
Put this to use
Johnson & Johnson Vision Care, Inc. ranks #225 of 1,925 by all-tracks total payments, led by "Compensation for Services Other Than Consulting".
- See where Johnson & Johnson Vision Care, Inc. sits among every top spender on the full leaderboard. Top 100 by total payments
- Compare "Compensation for Services Other Than Consulting" spend across every manufacturer, not just Johnson & Johnson Vision Care, Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.